selected scholarly activity
-
conferences
- 2. Abstract Title: Canadian Practice Patterns on Use of Catheter-Directed Thrombolysis for Lower Limb Deep Vein Thrombosis: Results of a National Survey. Thrombosis Research. 3-4. 2018
- Quantification of Cell-free DNA in Red Blood Cell Concentrates Produced via Buffy Coat or Whole Blood-Filtered Methods. Transfusion. 9A-9A. 2015
- Feasibility of comparing intermittent pneumatic compression vs. a novel device for prevention of venous thromboembolism in trauma patients with contraindication to anticoagulation. Journal of Thrombosis and Haemostasis. 726-726. 2015
- Quantification of cell free DNA in red blood cell concentrates produced via buffy coat (B1) OR whole blood (B2) methods. Journal of Thrombosis and Haemostasis. 468-468. 2015
- Characterization of B-Cell Lymphoma Unclassifiable with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma: A Ten Year Retrospective Review. Modern Pathology. 295A-295A. 2011
- Characterization of B-Cell Lymphoma Unclassifiable with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma: A Ten Year Retrospective Review.. Laboratory Investigation. 295A-295A. 2011
- Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia. Blood. 987-988. 2009
-
journal articles
- JTH in Clinic - Choosing the optimal oral anticoagulant for stroke prevention in atrial fibrillation: direct oral anticoagulants vs. vitamin K antagonists.. Journal of Thrombosis and Haemostasis. S1538-7836(24)00695-0. 2024
- Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.. Thrombosis and Haemostasis. 2024
- FRAIL-AF Study: More Bleeding With DOACs Compared With VKAs in Patients With Frailty?. Canadian Journal of Cardiology. 40:1377-1378. 2024
- Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors. Journal of Thrombosis and Haemostasis. 22:2761-2766. 2024
- Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease. Canadian Journal of Surgery. 67:E1-E6. 2024
- Clinical Studies with Anticoagulants that Have Changed Clinical Practice. Seminars in Thrombosis and Hemostasis. 49:242-254. 2023
- Impact of Rabeprazole on APO-Dabigatran Exposure in Healthy Volunteers. CJC OPEN. 5:1-7. 2023
- Multidisciplinary Practice Variations of Anti-Thrombotic Strategies for Free Tissue Transfers. Plastic Surgery. 30:343-352. 2022
- Building Your Peripheral Artery Disease Toolkit: Medical Management of Peripheral Artery Disease in 2022. Canadian Journal of Cardiology. 38:634-644. 2022
- Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort. Research and Practice in Thrombosis and Haemostasis. 6:e12650-e12650. 2022
- Patient and physician perspectives on the use and outcome measures of mHealth apps: Exploratory survey and focus group study. Digital Health. 8:205520762211027-205520762211027. 2022
- Medical Therapy Following Urgent/Emergent Revascularization in Peripheral Artery Disease Patients (Canadian Acute Limb Ischemia Registry [CANALISE I]). CJC OPEN. 3:1325-1332. 2021
- Prevention and Management of Urgent/Emergent Limb Ischemia. Current Cardiology Reports. 23:41. 2021
- A National Canadian Survey of Antithrombotic Therapy After Urgent and Emergent Limb Revascularization. Canadian Journal of Cardiology. 37:504-507. 2021
- Feasibility of a Web-Based Platform (Trial My App) to Efficiently Conduct Randomized Controlled Trials of mHealth Apps For Patients With Cardiovascular Risk Factors: Protocol For Evaluating an mHealth App for Hypertension. JMIR Research Protocols. 10:e26155-e26155. 2021
- Mortality Benefit in the Compass Trial: is It Related to Superior Statistical Power Or Better Efficacy and safety?. Future Cardiology. 17:175-182. 2021
- Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose. Journal of the American College of Cardiology. 76:2906-2907. 2020
- Current Challenges in Diagnosis of Venous Thromboembolism. Journal of Clinical Medicine. 9:3509-3509. 2020
- Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review. Thrombosis and Haemostasis. 120:1323-1329. 2020
- Prevention of Venous Thromboembolism in 2020 and Beyond. Journal of Clinical Medicine. 9:2467-2467. 2020
- Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?. Thrombosis Research. 186:13-19. 2020
- Which app is right for my CVD patient?. Heart and Metabolism. 17-20. 2020
- Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios. Current Cardiology Reports. 21:115. 2019
- What do Physicians Need to Know in Order to ‘Prescribe’ Mobile Applications to Patients with Cardiovascular Disease?. Personalized Medicine. 16:263-268. 2019
- Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis. 119:668-674. 2019
- NOACs only for those who cannot tolerate a VKA: where is the evidence?. Acta Cardiologica. 74:17-20. 2019
- In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets. Thrombosis and Haemostasis. 118:1895-1901. 2018
- Low-dose Rivaroxaban Plus Aspirin for the Prevention of Cardiovascular Events: an Evaluation of COMPASS. Future Cardiology. 14:443-453. 2018
- Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada. Journal of Thrombosis and Thrombolysis. 46:310-315. 2018
- Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study. Research and Practice in Thrombosis and Haemostasis. 2:684-688. 2018
- Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery. European Journal of Haematology. 101:362-367. 2018
- The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series. Tijdschrift voor Medisch Onderwijs. 7:219-223. 2018
- Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 131:2151-2160. 2018
- Assessing renal function in patients receiving DOACs: Cockcroft-Gault versus estimated glomerular filtration rate. Thrombosis Research. 157:165-166. 2017
- Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial. TH Open. 01:e139-e145. 2017
- Clinical Implications of Reversal Agents for Direct Oral Anticoagulants. Future Cardiology. 13:153-159. 2017
- Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods. Journal of Blood Transfusion. 2016:1-5. 2016
- Enhanced TRAP-induced platelet aggregation with dabigatran — Clinical perspective. Thrombosis Research. 138:61-62. 2016
- Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants. Expert Review of Cardiovascular Therapy. 13:1213-1223. 2015
- Comparison of the Proinflammatory and Procoagulant Properties of Nuclear, Mitochondrial, and Bacterial DNA. Shock. 44:265-271. 2015
- Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation. ACP journal club. 162:JC4-JC4. 2015
- Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism. Vascular Health and Risk Management. 11:343-343. 2015
- Alpha-1 proteinase inhibitor M358R reduces thrombin generation when displayed on the surface of cells expressing tissue factor. Thrombosis Research. 134:1142-1149. 2014
- Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura. Transfusion. 52:2517-2523. 2012
- Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study. Leukemia and Lymphoma. 53:57-63. 2012
- Management of Bleeding Complications in the Anticoagulated Patient. Seminars in Hematology. 48:285-294. 2011
- MDs 'R' Us(R): Gifts for your favourite specialist. CANADIAN MEDICAL ASSOCIATION JOURNAL. 175:1576-1577. 2006
- MDs 'R' Us(R): gifts for your favourite specialist. CANADIAN MEDICAL ASSOCIATION JOURNAL. 171:1508-1509. 2004
- MDs 'R' Us: holiday ideas. CANADIAN MEDICAL ASSOCIATION JOURNAL. 169:1326-1327. 2003
- MDs 'R' Us: holiday ideas for that special physician:. CANADIAN MEDICAL ASSOCIATION JOURNAL. 169:1326-1327. 2003